-
CXO -- Booming industry and strong demand for R&D
In recent years, with the deepening of the understanding of various targets and the progress of new technologies, innovative drug research and develop...
2022-08-22 16:47 -
FDA Approves Bluebird Gene Therapy Zynteglo
On August 17, 2022, the U.S. FDA announced that it has approved the gene therapy Zynteglo (betibeglogene autotemcel, beti-cel) developed by bluebird b...
2022-08-22 14:17 -
Chemical API market is building core competitive advantages
With high R&D investment, Chinese CRO/CDMO companies are able to efficiently undertake outsourced R&D and manufacturing business related to BigPharma ...
2022-08-19 15:25 -
Overview Of The Development Of China's Pharmaceutical Industry 2022
In recent years, the scale of China's pharmaceutical market has been growing at a relatively fast pace. Data shows that China's pharmaceutical market ...
2022-08-18 16:44 -
Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022
At present, the veterinary drug raw material market is stable, and themarket inquiries and negotiations are still mainly concentrated on doxycyclinehy...
2022-08-18 14:45 -
The Global API Industry Pattern is Gradually Shifting to China and India
Before the 1990s, Europe and the United States were the most important API production areas in the world, with large-scale industries and advanced tec...
2022-08-17 14:05 -
FDA Issues Drug Statement, Merck's Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen
Recently, the US Food and Drug Administration (FDA) official website issued a drug statement: The FDA recently found the nitrosamine impurity Nitroso-...
2022-08-16 10:37 -
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
On August 2, 2022, Hengrui Medicine issuedan announcement that the company received the approval and issuance of the"Drug Clinical Trial Approval Lett...
2022-08-12 14:46 -
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)
Sulfonamide products were generally in a low-key and weak state in the first half of this year, which was greatly affected by the market conditions of...
2022-08-12 14:28 -
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
Doxycycline hydrochloride, the market price is 570-590. In July, the price increased by more than 100 yuan, up 26.1% month-on-month.
2022-08-12 14:00
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products